The global healthcare services market was worth $9.25 trillion in 2025 and is projected to reach $11.22 trillion by 2029, growing at a CAGR of 4.9%. Simultaneously, the global healthcare analytics market, a core driver of insight-led innovation, is projected to grow from $57.6 billion in 2025 to $160.39 billion by 2030, at a 22.92% CAGR. And the broader AI in healthcare market is forecast to surge from $39.25 billion in 2024 to a staggering $504.17 billion by 2032, implying a 44% CAGR.
These numbers don’t just reflect industry growth; they reveal a major shift toward insight-led innovation. In a high-stakes sector where every decision affects lives, healthcare market research has become a strategic imperative. Whether it’s accelerating drug development, improving therapy adoption, engaging physicians, or decoding patient behavior, research is the engine that powers smarter care.
Why Human-centered Healthcare Market Research is No Longer Optional
At Markelytics, we believe healthcare research should do more than measure. It should listen, empathize, and reflect the real-world complexity of care. From pediatricians tuning out product noise to patients caught between trust and affordability, from neurologists stalled by coverage delays to dentists navigating dual markets, every decision is shaped by more than just data points.
That’s why we go beyond surveys and surface stats. We immerse ourselves in the everyday realities of healthcare professionals and stakeholders to capture the subtle signals that drive behavior.
Because in healthcare, understanding the human context isn’t just helpful, it’s essential. Here’s how we’ve helped clients turn insight into smarter, more meaningful action.
1. Listening to Pediatricians: Infant Nutrition Insights
It was the busy U.S. holiday season, a time when connecting with physicians is often the hardest. Yet, we partnered with pediatricians nationwide to uncover their unfiltered perceptions of infant nutrition products and their experiences with brand representatives. Reaching them meant working late into the evenings and navigating packed schedules, but our team remained committed. The result: 100% validated data quality, giving our client the confidence to refine their engagement strategies and ensure alignment with clinical expectations. Read Case Study
2. A Treatment Patterns in APAC: Perspectives from Rheumatologists
Across Asia-Pacific, managing rheumatoid arthritis presents a unique set of challenges from cultural and regulatory differences to unequal access to advanced therapies. To capture these nuances, we engaged 250 rheumatologists in China, India, Japan, and South Korea, creating a comparative analysis of treatment practices, prescribing behaviors, and patient preferences. Delivered through a detailed report and an interactive dashboard, the study highlighted both common barriers and regional differences, giving our client the clarity to design tailored strategies for diverse markets. Read Case Study
3. Understanding MS Therapies: Canadian Neurologist Study
Reaching neurologists is never easy, especially when their schedules are filled with patient care. Yet in just four weeks, we successfully engaged 60 Canadian neurologists to explore the therapies and prescriptions used in treating Multiple Sclerosis. With careful planning and persistent outreach, our team ensured 100% data quality, meeting tight timelines and earning commendation from the client for the precision and dedication shown throughout the project. Read Case Study
4. Dental Product Preferences: German Market
In Germany, as the year-end festive season unfolded, we sought to understand how dental professionals approached patient care and product use. Despite lower participation rates during this period, we successfully surveyed 109 dental professionals using CATI and CAM methods. The findings shed light on how patients’ choices were shaped by factors like accessibility and trust, equipping our client with actionable insights into market positioning and product adoption strategies. Read Case Study
5. Rare Disease Studies in Oncology & Hematology: U.S. Insights
Researching rare diseases means venturing into some of the most complex and hard-to-reach areas of healthcare. In the U.S., we carried out four specialized studies covering conditions such as ROS1+, MET Exon14+, NTRK Fusion+, Paroxysmal Nocturnal Hemoglobinuria (PNH), Cold Agglutinin Disease (CAD), Immune Thrombocytopenic Purpura (ITP), Acquired Thrombotic Thrombocytopenic Purpura (aTTP), and Hunter Syndrome. Working with 12 to 30 hematology and oncology specialists per project, we used custom recruitment and phone-to-web methods to overcome low incidence rates. Despite these challenges, every study was successfully completed within the set timelines, providing our client with rare but invaluable insights into diagnostic and treatment approaches. Read Case Study
What We Can Do for the Healthcare Sector
At Markelytics, we approach healthcare market research with deep respect for the stakes involved. This isn’t just about improving market share, it’s about improving lives. Covering healthcare professionals from 75+ medical specialties, we work with global healthcare agencies & brands to surface what truly shapes decision-making clinical, emotional, and systemic.
Our strength lies in global reach and data quality along with designing the right methodology for the right respondent, whether it’s a stretched rural GP, a specialist treating complex mutations, or a patient navigating affordability and trust. We bring agility where timelines are tight, cultural understanding where messaging must resonate, and validation where outcomes can’t afford uncertainty.
This is more than research. It’s strategy, empathy, and action built into every phase of the healthcare journey.
From Clarity to Confidence: Your Research Ally in Healthcare
In healthcare, growth isn’t just about investment; it’s about insight. The true differentiator is how well healthcare brands listen to humans behind the statistics. Your next strategic leap comes from understanding not just the numbers, but the stories they tell.
That’s where we come in.
If you’re ready to tap into lived experiences, hear what patients and professionals are really saying, and build solutions grounded in insight, let’s connect.